OHSU
Return to Listing

1 result(s) for Vidaza

PI Name Protocol # Title
Kim-Hien Dao IRB00005669 A Phase II Study of the Efficacy, Safety and Determinants of Response to 5-Azacitidine (Vidaza®) in Patients with Chronic Myelomonocytic Leukemia (CMML)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080
 

You may qualify for additional trials within our Phase 1 Program